CHANG EDCON,NOTZ WOLFGANG REINHARD LUDWIG,WALLACE MICHAEL B
申请号:
AP201508236
公开号:
AP201508236A0
申请日:
2013.07.08
申请国别(地区):
AP
年份:
2015
代理人:
摘要:
Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with PI3Kδ.